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Abstract: 5-Hydroxy-1-oxo-5-cholestan-3-yl acetate (11) was prepared in 5 steps starting
from (E)-3-acetoxy-5,10-seco-1(10)-cholesten-5-one (6). Treatment of the 1-oxo-5-hy-
droxy derivative 11 with lead tetraacetate (LTA) (under thermal or hypoiodite conditions) or
with mercuric oxide/iodine (HgO/I2) reagent resulted in the oxidative -fragmentation of
the C(5)–C(10) bond affording 1,5-dioxo-5,10-secocholest-10(19)-en-3-yl acetate (12), in
different yields, depending on the reagent. Also the stereochemistry of the 1,6-cyclization
product 13, formed by transannular cyclization of the 1,5-diketone 12 on silica gel, is
discussed in this work.
Keywords: 5-Hydroxy-1-oxo-5-cholestan-3-yl acetate, 1,5-dioxo-5,10-secocho-
lest-10(19)-en-3-yl acetate, -fragmentation, transannular cyclization.
INTRODUCTION
It is well known that the alkoxy radical i (generated by the oxidation of the 5-hydroxy
steroids 1 and 2 with lead tetraacetate (LTA) under thermal or photolytic conditions or with
hypoiodite-forming reagents) readily undergoes -fragmentation involving scission of the
C(5)–C(10) bond, to afford, via the C(10)-radical intermediate ii, the diastereomeric (Z)-
and (E)-1(10)-unsaturated 5,10-secosteroidal 5-ketones 3 and 4 in different proportions
and, depending on the oxidant used, in high yield (Scheme 1).1–3
The direction of -fragmentation in 1 and 2 to give exclusively the 5,10-secoketones
3 and 4 was explained by the stability of the tertiary C-radical intermediate ii, due to the
presence of the angular Me(19) group at the C(10)-radical center.
In accordance with such an explanation, it was anticipated that other 5-hydroxy steroids
with similar structures and with the same reagents should react in the same way. However,
when LTA oxidations (thermal and hypoiodite) of the 5-hydroxy-8,9-seco-8,9-diketone 5, a
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substrate with a polar oxo-group located at the -position to the corresponding C(10)-radical
center (type ii), were performed under similar experimental conditions, the only obtained
product was an unresolvable mixture of the 7-, 11- and 14-acetoxy derivatives arising from the
competing acetoxylation of the -positions next to the C(8)- and C(9)-oxo groups.
On the other hand, when the oxidative fragmentation of the C(5)–C(10) bond in
compound 5 was attempted with HgO/I2 reagent, practically all the starting material
remained unchanged (recovery being  82 %, while the rest was an unresolvable mixture)
(Scheme 2).4
The resistance of compound 5 to undergo oxidative -fragmentation of its C(5)–C(10)
bond was explained by strong hydrogen bonding between the 5-OH group and the 9-oxo
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Scheme 1.
Scheme 2.
function. As a consequence of this interaction, the formation of the alkoxy radical was sup-
pressed.
RESULTS AND DISCUSSION
In order to obtain more information concerning the influence of an oxo-group in the
-position to the C(10) on the oxidative fragmentation of the C(5)–C(10) bond, in the present
work the possibility of inducing oxidative -fragmentation of 5-hydroxy-1-oxo-5-cho-
lestan-3-yl acetate (11) was investigated.
For the introduction of an oxygen function at the C(1)-position, the ten-membered
ring containing (E)-3-acetoxy-5,10-seco-1(10)-cholesten-5-one (6) was required. This
compound was prepared from cholestane-3,5-diol 3-acetate according to the procedure
given in Ref. 3. Substrate 11 was then synthesized in 5 steps, as shown in Scheme 3.
UV irradiation of 6 in acetone solution with a high pressure mercury lamp (TQ 150
Z2) afforded a photoproduct (Paterno-Büchi reaction) with an oxetane structure, i.e.
1,5-epoxy-5-cholestan-3-yl acetate (7)5 in 36.5 % yield. Treatment of the oxetane
derivative 7 with hydroiodic acid in glacial acetic acid at 5 ºC resulted in the opening of
the four-membered ether ring and the formation of cholest-5-en-1,3-diol 3-acetate (8)
in high yield (78.0 %).5 The epoxy derivative 9 was prepared by m-chloroperbenzoic
acid (MCPBA) oxidation of 8 (in 83.5 % yield).6 This product under conditions of
catalytic hydrogenation (performed over PtO2 in acetic acid solution) gave 5-chole-
stan-1,3,5-triol 3-acetate (10)7 (35.7 %). Jones oxidation of the triol-monoacetate 10
in acetone solution at –5 ºC afforded the 5-hydroxy-1-oxo-5-cholestan-3-yl acetate
(11) in 78.6 % yield.
Oxidations of alcohol 11 were performed with hypoiodite-forming reagents and LTA
(thermal) under conditions similar to those previously applied to compounds 1, 2 and 5.1–4
The HgO/I2 version of the hypoiodite reaction of 11 performed with an excess of
oxidant in CCl4 solution by irradiation with a 15 W-lamp at 220 V at room temperature for
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Scheme 3.
90 min in the presence of air gave, besides starting material 11 (20 %), an unresolvable
complex mixture from which not one product with a defined structure could be isolated.
The same results were obtained when the reaction was performed under O2. However,
when the above irradiation was performed under Ar, the resulting mixture of reaction
products, after separation by column chromatography on silica gel, gave the 1,5-dio-
xo-5,10-secocholest-10(19)-en-3-yl acetate (12) (38 %), the starting compound 11 (27
%) and the cyclization product 13 (28 %) (Scheme 4).
The structure of the product 12 was deduced from its analytical and spectral data (IR,
1H-NMR, 13C-NMR, MS). In the IR spectrum, the absorption of the 1-oxo group migrates from
1716 to 1670 cm–1, indicating an ,-unsaturated carbonyl, and the absorption for the original
5-hydroxyl group was missing and instead a new absorption at 1701 cm–1 for the 5-oxo group
appeared. In the 13C-NMR spectrum, a new singlet appeared at 207.7 ppm for C(5). The
presence of the exocyclic methylidene group CH2=C(10) was evident from the IR spectrum
(absorptions at 3100 and 1620 cm–1) and confirmed by 1H- and 13C-NMR data. Instead of the
signal for the Me(19) group, the 1H-NMR spectrum showed a pair of singlets at 5.83 and 6.15
ppm, and the 13C-NMR spectrum showed a triplet at 124.6 ppm for C(19) and a singlet at 155.0
ppm for C(10). Also, in the 13C-NMR spectrum, a singlet at 199.4 ppm for C(1) in the
1,5-diketone 12 was situated upfield when compared to the resonance at 209.4 ppm for C(1) in
compound 11, indicating the influence of the exocyclic methylidene group in the -position.
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Scheme 4.
Compound 13 is a secondary reaction product, formed by intramolecular 1,6-cycli-
zation of the 1,5-diketone 12. This was confirmed by prolonged stirring (24 hours) of com-
pound 12 with SiO2 in toluene solution which afforded, besides the starting material, only
one product, i.e. compound 13 (Scheme 5).
The structure of 13 was deduced from its analytical and spectral data (IR, 1H-NMR,
13C-NMR, MS). In the IR spectrum, the absorption of the 1-oxo group was replaced by a
new absorption at 3483 cm–1 of the 1-hydroxy group. The IR band at 1643 cm–1 indicates
that the exocyclic methylidene group still existed, which was confirmed by 1H- and
13C-NMR data. Its 1H-NMR spectrum contained a pair of singlets at 4.86 and 5.00 ppm of
the CH2=C(10) group. Also, the
13C-NMR spectrum contained the following cha-
racteristic signals: a triplet at 105.4 ppm of the C(19), a singlet at 74.0 ppm of the C(1) and
a doublet at 56.0 ppm of the C(6). The cis-1,6-stereochemistry for the cyclization
product 13 was deduced from its 1H-NMR spectral characteristics. The signal for the
H

–C(6) (due to the deshielding influence by the 5-carbonyl group), was shifted downfield
and appeared at 2.88 ppm as a fine doublet of doublets, indicating a dihedral angle of about
60º (J = 5.5 Hz) between the H

–C(6) and H

–C(7) and 180º (J = 13.5 Hz) between the
H

–C(6) and H2C(7), and the “W” arrangement of the H–C(6)–C(5)–C(4)–H (J = 1.8
Hz), which is present only in the 1,6-isomer.
The LTA version of the hypoiodite reaction8 of 11 was carried out with a large excess
of oxidant in benzene solution by irradiation with a 15 W-lamp at 220 V at room tempera-
ture for 30 min, i.e., until 11 had been completely consumed. The resulting mixture was
separated by column chromatography (silica gel), affording the previously described com-
pound 12 in a very good yield of 73 % and the cyclization product 13 in a 10 % yield
(Scheme 4).
The thermal LTA oxidation of 11 was carried out with an excess of oxidant in the pres-
ence of CaCO3 in boiling benzene for 48 h (practically, the reaction mixture was not
changed after 4 h). After separation by chromatography on silica gel, the reaction mixture
gave 1,5-dioxo-5,10-secocholest-10(19)-en-3-yl acetate (12) (18 %), the starting com-
pound 11 (43 %) and the cyclization product 13 (7 %) (Scheme 4).
From the above results it follows that the described oxidations of 5-hydroxy-1-oxo-5-cho-
lestan-3-yl acetate (11) proceed (exclusively with HgO/I2 and LTA/I2 under Ar) as
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expected via the C(10)-centered radical C (Scheme 6) which is formed according to the
generally accepted mechanism,8,9 i.e., the homolysis of the O–I bond in the primarily
formed species A is followed by fragmentation of the C(5)–C(10) bond in the thus
obtained alkoxy radical B. The radical C is then stabilized by elimination of a H-atom from
the Me(19) to give the 10-methylidene seco ketone 12.
The formation of the cyclization product 13 may be explained by an acid-catalyzed
intramolecular aldol reaction in compound 12 during the chromatography on SiO2
(Scheme 7).
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EXPERIMENTAL
General.
Prep. column chromatography: silica gel Merck 0.063–0.200 mm. TLC: control of reaction and
separation of products on silica gel 60 F254 (Merck) with benzene/EtOAc 9:1, 8:2 and 7:3, detection with 50
% aq. H2SO4 soln. Mps.uncorrected. IR spectra: Perkin-Elmer-337 spectrophotometer;  in cm
-1. NMR
spectra: Varian Gemini 200 (1H at 200 MHz, 13C at 50 MHz); CDCl3 soln. at r.t., TMS as internal standard;
chemical shifts in ppm as  values. J in Hz. Mass spectra: Finnigan-MAT 8230.
1 5-Epoxy-5-cholestan-3-yl acetate (7)5
A stirred solution of (E)-5-oxo-5,10-secocholest-1(10)-en-3-yl acetate (6) (2 g) in acetone (200 ml)
was irradiated with a high pressure mercury lamp TQ 150 Z2 (Hanau) at room temperature for 6 h,
evaporated to dryness and the oily residue (2.16 g) chromatographed on silica gel (100 g). Elution with
toluene-EtOAc (98:2) gave the unchanged (E)-secoketone 6 (0.36 g, 18 %). Further elution with the same
eluent gave 1,5-epoxy-5-cholestan-3-yl acetate (7) (0.73 g, 36.5 %) as a white solid, m.p. 101–102 ºC
(from acetone). D = +202 (c = 1.0). IR (CH2Cl2): 1732, 1238, 1025.
1H-NMR: 0.68 (s, 3H, CH3(18)),
0.85 (s, 3H, CH3(19)), 0.88 (d, 6H, CH3(26), CH3(27)), 0.92 (d, 3H, CH3(21)), 2.07 (s, 3H, AcO), 2.41 (dd, J
= 9.8, 14.8, 1H, H

–C(4)), 2.71 (m, 1H, H

–C(2)), 3.99 (d, J = 5.8, 1H, H–C(1)), 5.24 (m, 1H, H–C(3)).
13C-NMR: 170.7 (s, OCOCH3), 88.6 (s, C(5)), 83.2 (d, C(1)), 66.7 (d, C(3)), 56.1 (2d, C(14), C(17)), 47.0 (d,
C(9)), 45.4 (s, C(10)), 42.4 (s, C(13)), 39.8 (t, C(12)), 39.5 (t, C(24)), 38.6 (t, C(4)), 36.1 (t, C(22)), 35.8 (d,
C(20)), 34.1 (d, C(8)), 31.5 (t, C(2)), 31.0 (t, C(6)), 28.1 (t, C(16)), 28.0 (d, C(25)), 27.8 (t, C(7)), 24.4 (t,
C(15)), 23.8 (t, C(23)), 23.1 (t, C(11)), 22.8 (q, C(27)), 22.5 (q, C(26)), 21.3 (q, OCOCH3), 18.7 (q, C(21)),
11.8 (q, C(18)), 11.7 (q, C(19)). MS: m/z = 444 (M+). Anal. calcd. for C29H48O3 (444.696): C 78.33, H 10.88;
found: C 78.18, H 10.87.
Cholest-5-en-1,3-diol 3-acetate (8)5
The oxetane derivative 7 (2.30 g) was dissolved in glacial AcOH (47 ml) and cooled to 5 ºC. To this
semi-solid solution, a cooled solution of hydroiodic acid (0.98 ml 57 % HI) in glacial AcOH (30.5 ml) was
added portionwise. The resulting mixture was left at 5 ºC for 30 min, diluted with H2O and extracted with
Et2O. The ethereal extract was washed with H2O, saturated aq. NaHCO3 and H2O, dried over Na2SO4 and
evaporated to dryness, leaving a crystalline solid (2.4 g) which was chromatographed on SiO2 (100 g). Elu-
tion with toluene-EtOAc (95:5) gave cholest-5-en-1,3-diol 3-acetate (8) (1.80 g, 78 %), m.p. 166–168 ºC
(from acetone). D = – 41 (c = 0.7). IR (KBr): 3450, 3020, 1730, 1275, 1040.
1H-NMR: 0.68 (s, 3H,
CH3(18)), 0.86 (d, 6H, CH3(26), CH3(27)), 0.91, (d, 3H, CH3(21)), 1.04 (s, 3H, CH3(19)), 2.03 (s, 3H, AcO),
3.86 (brs, 1H, H–C(1)), 5.03 (heptet, 1H, H–C(3)), 5.61 (bd, J = 5.2, 1H, H–C(6)). 13C-NMR: 170.6 (s,
OCOCH3), 136.2 (s, C(5)), 126.5 (d, C(6)), 72.5 (d, C(1)), 69.5 (d, C(3)), 56.5 (d, C(17)), 56.0 (d, C(14)), 42.2
(s, C(13)), 41.7 (s, C(10)), 41.4 (d, C(9)), 39.4 (2t, C(12), C(24)), 37.2 (t, C(2)), 36.1 (t, C(22)), 35.7 (d,
C(20)), 34.4 (t, C(4)), 31.7 (d, C(8)), 31.7 (t, C(7)), 28.1 (t, C(16)), 28.0 (d, C(25)), 24.3 (t, C(15)), 23.8 (t,
C(23)), 22.8 (q, C(27)), 22.5 (q, C(26)), 21.3 (q, OCOCH3), 20.1 (t, C(11)), 19.3 (q, C(21)), 18.7 (q, C(19)),
11.8 (q, C(18)). MS: m/z = 384 (M+ – 60, 99 %). Anal. calcd. for C29H48O3 (444.696): C 78.33, H 10.88;
found: C 78.31, H 10.69.
5,6-Epoxy-5-cholestan-1,3-diol 3-acetate (9)6
A solution of 8 (1.00 g) in CH2Cl2 (25 ml) was treated with 85 % m-chloroperbenzoic acid (500 mg in
25 ml CH2Cl2) at room temperature for 1 h. After the usual work–up, the obtained residue (0.980 g, 96.4 %)
was recrystallized from acetone to give 5,6-epoxy-5-cholestan-1,3-diol 3-acetate (9) (0.865 g, 83.5 %),
m.p. 156 ºC. D = –11.0 (c = 1.09). IR (KBr): 3450, 3030, 1730, 1710, 1275, 1042.
1H-NMR: 0.62 (s, 3H,
CH3(18)), 0.86 (d, 6H, CH3(26), CH3(27)), 0.89 (d, 3H, CH3(21)), 1.10 (s, 3H, CH3(19)), 2.02 (s, 3H, AcO),
2.82 (d, J = 4.8, 1H, H–C(6)), 3.90 (brs, 1H, H–C(1)), 5.30 (heptet, 1H, H–C(3)). 13C-NMR: 170.1 (s,
OCOCH3), 72.8 (d, C(3)), 67.6 (d, C(1)), 64.0 (s, C(5)), 56.7 (d, C(17)), 56.5 (d, C(6)), 55.8 (d, C(14)), 42.3
(2s, C(10), C(13)), 39.4 (t, C(24)), 39.0 (t, C(12)), 36.6 (d, C(9)), 36.1 (d, C(20)), 35.7 (t, C(4)), 35.6 (t, C(2)),
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34.7 (t, C(22)), 29.8 (d, C(8)), 28.6 (t, C(16)), 28.0 (d, C(25)), 27.9 (t, C(7)), 24.1 (t, C(15), 23.8 (t, C(23)),
22.8 (q, C(27)), 22.5 (q, C(26)), 21.2 (q, OCOCH3), 19.7 (t, C(11)), 18.6 (q, C(21)), 16.5 (q, C(19)), 11.8 (q,
C(18)). Anal. calcd. for C29H48O4 (460.699): C 75.61, H 10.50; found: C 74.43, H 10.68. CI-MS: m/z = 461
(M+ + 1).
5-Cholestan-1,3,5-triol 3-acetate (10)7
A solution of 9 (1.8 g) in AcOH–EtOH (10:1, 110 ml) was hydrogenated over PtO2 (180 mg) in a Parr
Hydrogenator at room temperature and 3 atm pressure, for 13 h. After removal of the catalyst and solvent, the
residue was chromatographed on SiO2 (120 g). Elution with toluene–EtOAc (95:5) afforded the unchanged
starting compound 9 (0.86 g, 44.0 %). Elution with toluene–EtOAc (90:10) gave 5-cholestan-1,3,5-triol
3-acetate (10) (0.70 g, 35.7 %), m.p. 178–179 ºC (from acetone). IR (KBr): 3368, 1737, 1467, 1374, 1247.
1H-NMR: 0.66 (s, 3H, CH3(18)), 0.85 (d, 6H, CH3(26), CH3(27)), 0.92 (d, 3H, CH3(21)), 0.94 (s, 3H,
CH3(19)), 2.03 (s, 3H, AcO), 2.99 (s, 1H, OH–C(5)), 3.82 (m, 2H, H–C(1) and OH–C(1)), 5.41 (heptet, 1H,
H–C(3)). 13C-NMR: 170.8 (s, OCOCH3), 77.3 (s, C(5)), 74.0 (d, C(3)), 67.8 (d, C(1)), 56.2 (d, C(17)), 56.0
(d, C(14)), 42.7 (s, C(13)), 41.4 (s, C(10)), 40.1 (d, C(9)), 39.7 (t, C(12)), 39.4 (t, C(24)), 36.1 (t, C(4)), 35.8
(d, C(20)), 35.1 (t, C(22)), 34.7 (t, C(6)), 34.6 (d, C(8)), 29.6 (t, C(2)), 28.2 (t, C(16)), 28.0 (d, C(25)), 25.6 (t,
C(7)), 24.1 (t, C(15)), 23.9 (t, C(23)), 22.8 (q, C(27)), 22.5 (q, C(26)), 21.4 (q, OCOCH3), 20.7 (t, C(11)), 18.6
(q, C(21)), 16.6 (q, C(19)), 12.1 (q, C(18)). CI-MS: m/z = 445 (463–18), 385 (463–60–18).
5-Hydroxy-1-oxo-5-cholestan-3-yl acetate (11)
To a cooled (–5 ºC) solution of 10 (1.26 g) in acetone (165 ml), a slight excess of Killiani’s chromic acid
solution was added with constant stirring. After 20 min ice-cold H2O was added, the precipitate was filtered
off, washed thoroughly with H2O and air-dried to give a residue (1.2 g, 95.7 %), which was chromatographed
on SiO2 (40 g). Elution with toluene–EtOAc (95:5) afforded 5-hydroxy-1-oxo-5-cholestan-3-yl acetate
(11) which was recrystallized from acetone (0.98 g, 78.6 %), m.p. 138.5–140 ºC. IR (KBr): 3494, 3454, 1716,
1377, 1245, 1032. 1H-NMR: 0.66 (s, 3H, CH3(18)), 0.85 (d, 6H, CH3(26), CH3(27)), 0.88 (d, 3H, CH3(21)),
1.28 (s, 3H, CH3(19)), 2.04 (s, 3H, AcO), 2.62 (dd, J = 6.8, 13.4, 1H, H–C(4)), 2.81 (dd, J = 10.8, 12.8, 1H,
H

–C(2)), 5.30 (m, H–C(3)). 13C-NMR: 209.4 (s, C(1)), 170.2 (s, OCOCH3), 76.0 (s, C(5)), 69.2 (d, C(3)),
56.2 (d, C(17)), 55.8 (d, C(14)), 53.8 (s, C(10)), 43.1 (t, C(2)), 42.7 (s, C(13)), 41.0 (d, C(9)), 39.8 (t, C(12)),
39.4 (t, C(24)), 39.2 (t, C(4)), 36.1 (d, C(22)), 35.8 (t, C(20)), 34.9 (d, C(8)), 33.6 (t, C(6)), 28.0 (t, C(16)), 27.9
(d, C(25)), 24.9 (t, C(7)), 24.0 (t, C(15)), 23.9 (t, C(23)), 22.8 (t, C(11)), 22.8 (q, C(27)), 22.5 (q, C(26)), 21.2
(q, OCOCH3), 18.5 (q, C(21)), 16.4 (q, C(19)), 12.3 (q, C(18)). MS: m/z = 460 (M
+), 443 (460–17), 401
(460–59), 383 (460–60–17).
Oxidation of 5-hydroxy-1-oxo-5-cholestan-3-yl acetate (11)
(i) Hypoiodite mercuric oxide/iodine oxidation. A stirred suspension of 11 (100 mg, 0.217 mmol),
yellow HgO (325 mg, 1.5 mmol) and I2 (437 mg, 1.7 mmol) in CCl4 (30 ml) was irradiated with a 15 W (220
V) fluorescent lamp for 90 min without heating. All the time argon was introduced through the reaction
mixture. The solid was removed by filtration, washed with Et2O, and filtrate washed successively with water,
10 % aq. Na2S2O3, saturated NaHCO3 and water, dried over Na2SO4 and evaporated to dryness. The
resulting mixture (111 mg) was chromatographed on silica gel (10 g). Elution with toluene-EtOAc (99:1,
98:2, 97:3) afforded a complex mixture (11 mg) which was not further investigated. Toluene–EtOAc (96:4)
eluted 1,5-dioxo-5,10-secocholest-10(19)-en-3-yl acetate 12 which was recrystallized from acetone/metha-
nol (38 mg, 38 %), m.p. 157–158 ºC. IR (KBr): 1735, 1701, 1672, 1620, 1251, 1032. 1H-NMR: 0.74 (s, 3H,
CH3(18)), 0.86 (d, 6H, CH3(26), CH3(27)), 0.90 (d, 3H, CH3(21)), 2.05 (s, 3H, AcO), 2.44 (m, 2H, H2–C(6)),
2.65 (dd, J = 3.5, 15.7, 1H, H–C(4)), 2.93 (d, J = 11.4, 1H, H–C(4)), 3.00 (ABq, J = 3.6, 2H, H2C(2)), 5.60 (m,
H–C(3)), 5.83 and 6.15 (2s, 2H, H2C(19)).
13C-NMR: 207.7 (s, C(5)), 199.4 (s, C(1)), 169.8 (s, OCOCH3),
155.0 (s, C(10)), 124.6 (t, C(19)), 68.8 (d, C(3)), 56.1 (d, C(17)), 54.2 (d, C(14)), 46.5 (t, C(4)), 44.5 (d, C(9)),
43.1 (t, C(2)), 42.5 (s, C(13)), 41.8 (t, C(12)), 39.7 (t, C(24)), 39.5 (t, C(6)), 38.3 (d, C(8)), 36.0 (t, C(22)), 35.7
(t, C(20)), 33.4 (t, C(7)), 28.0 (d, C(25)), 27.8 (t, C(16)), 26.8 (t, C(15)), 24.9 (t, C(11)), 23.8 (t, C(23)), 22.8
(q, C(27)), 22.5 (q, C(26)), 21.1 (q, OCOCH3), 18.6 (q, C(21)), 11.8 (q, C(18)), CI-MS: m/z = 459 (M
+ + 1).
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Further elution with the same eluent afforded the starting compound 11 (27 mg, 27 %).
Further elution with toluene–EtOAc (95:5) gave compound 13 (28 mg, 28 %). Oil. IR (KBr): 3483,
1732, 1708, 1643, 1269, 1028. 1H-NMR: 0.67 (s, 3H, CH3(18)), 0.85 (d, 6H, CH3(26), CH3(27)), 0.92 (d,
3H, CH3(21)), 2.08 (s, 3H, AcO), 2.20–2.64 (m, 4H, H2C(2), H2C(4)), 2.88 (fdd, J = 1.8, 5.5, 13.5, 1H,
H

–C(6)), 4.86 and 5.00 (2fs, J = 1.6, 2H, H2–C(19)), 5.38 (heptet, 1H, H–C(3)).
13C-NMR: 206.2 (s, C(5)),
170.2 (s, OCOCH3), 154.3 (s, C(10)), 105.4 (t, C(19)), 74.0 (s, C(1)), 69.2 (d, C(3)), 56.7 (d, C(17)), 56.0 (2d,
C(6), C(14)), 46.5 (t, C(4)), 42.8 (s, C(13)), 42.3 (d, C(9)), 41.1 (d, C(8)), 40.4 (t, C(2)), 39.4 (t, C(12)), 39.3 (t,
C(24)), 36.1 (t, C(22)), 35.8 (d, C(20)), 29.7 (t, C(7)), 28.2 (t, C(16)), 28.0 (d, C(25)), 25.3 (t, C(15)), 24.8 (t,
C(11)), 23.8 (t, C(23)), 22.8 (q, C(27)), 22.5 (q, C(26)), 21.2 (q, OCOCH3), 18.6 (q, C(21)), 12.0 (q, C(18)).
(ii) Hypoiodite lead tetraacetate/iodine oxidation. Astirred suspension of LTA(450 mg, 0.91 mmol), I2
(94 mg, 0.37 mmol) and 11 (100 mg, 0.217 mmol), in dry benzene was irradiated with a 15 W (220 V) fluo-
rescent lamp at room temperature for 30 min. All the time argon was introduced through the reaction mixture.
The solid was removed by filtration, washed with Et2O and filtrate washed successively with water, 10 % aq.
Na2S2O3, saturated NaHCO3 and water, dried over Na2SO4 and evaporated to dryness. The resulting mixture
(141 mg) was chromatographed on silica gel (10 g). Elution with toluene–EtOAc (99:1, 98:2, 97:3) afforded a
complex mixture (17 mg) which was not further investigated. Toluene–EtOAc (96:4) eluted 1,5-dio-
xo-5,10-secocholest-10(19)-en-3-yl acetate 12 which was recrystallized from acetone/methanol (73 mg, 73
%), m.p. 157–158 ºC.
Further elution with toluene–EtOAc (95:5) gave compound 13 (10 mg, 10 %).
(iii) Thermal lead tetraacetate oxidation. A suspension of 11 (100 mg, 0.217 mmol), LTA (450 mg,
0.900 mmol) and anh. CaCO3 (95 mg, 0.960 mmol) in anh. benzene (15 ml) was heated under reflux with
stirring for 48 h, after which time the starch-iodine test became negative. The cooled mixture was diluted with
Et2O, washed with water, sat. aq. NaHCO3 and water, dried over Na2SO4 and evaporated to dryness. The re-
sulting mixture (116 mg) was chromatographed on silica gel (20 g). Elution with toluene–EtOAc (99:1, 98:2,
97:3) afforded a complex mixture (15 mg, 15 %) which was not further investigated. Toluene–EtOAc (96:4)
eluted the 1,5-dioxo compound 12 (18 mg, 18 %).
Further elution with same eluent afforded the starting compound 11 (43 mg, 43 %).
Elution with toluene–EtOAc (95:5) gave the cyclic compound 13 (7 mg, 7 %).
Cyclization of 1,5-dioxo-5,10-secocholest-10(19)-en-3-yl acetate 12 on SiO2
1,5-Diketone 12 (40 mg) was stirred with SiO2 (Merck, 0.063–0.20 mm) in toluene (5 ml) for 24 h at
room temperature. After removal of the SiO2 and solvent the residue was chromatographed on SiO2 (4 g).
Elution with toluene–EtOAc (96:4) gave unchanged starting material 12 (18 mg, 45 %).
Further elution with toluene–EtOAc (95:5) afforded compound 13 (17.2 mg, 43 %).
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5-HIDROKSI-1-OKSO-5-HOLESTAN-3-IL-ACETATA
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Sintetizovan je 5-hidroksi-1-okso-5-holestan-3-il-acetat (11) u 5 faza polaze}i od
(E)-3-acetoksi-5,10-seko-1(10)-holesten-5-ona (6). Dejstvom olovo-tetraacetata (LTA) (pod ter-
mi~kim ili hipojoditnim uslovima), ili merkuri-oksid/jodnog reagensa (HgO/I2) na 1-ok-
so-5-hidroksi derivat 11, vr{i se oksidativna -fragmentacija wegove C(5)–C(10) veze, pri
~emu se dobija 1,5-diokso-5,10-sekoholest-10(19)-en-3-il-acetat (12), u razli~itim prinosima
u zavisnosti od upotrebqenog reagensa. Tako|e, diskutovana je stereohemija 1,6-cikliza-
cionog proizvoda 13, nastalog intramolekulskom ciklizacijom 1,5-diokso-5,10-seko jediwewa
12 na silika gelu.
(Primqeno 22. maja 2003)
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